1. Pre-Seminar CORE Reading Assignment
2. Pre-Seminar Problem Set
3. Post-Seminar Supplemental Reading
- Core 1
Goodman S. A dirty dozen: twelve p-value misconceptions [published correction appears in Semin Hematol. 2011 Oct;48(4):302]. Semin Hematol. 2008;45(3):135–140. doi:10.1053/j.seminhematol.2008.04.003
- Core 2
Streiner DL, Norman GR. Correction for multiple testing: is there a resolution?. Chest. 2011;140(1):16–18. doi:10.1378/chest.11-0523
- Core 3
Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials [published correction appears in JAMA. 2009 Oct 14;302(14):1532]. JAMA. 2009;302(9):977–984. doi:10.1001/jama.2009.1242
- Core 4
Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252–260. doi:10.1056/NEJMsa065779
- Core 5
Doshi P. Neuraminidase inhibitors--the story behind the Cochrane review. BMJ. 2009;339:b5164. Published 2009 Dec 8. doi:10.1136/bmj.b5164
- Core 6
Wang R, Lagakos SW, Ware JH, Hunter DJ, Drazen JM. Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med. 2007;357(21):2189–2194. doi:10.1056/NEJMsr077003
- Core Post 1
Begley CG, Ellis LM. Drug development: Raise standards for preclinical cancer research. Nature. 2012;483(7391):531–533. Published 2012 Mar 28. doi:10.1038/483531a
- Core Post 2
Windish DM, Huot SJ, Green ML. Medicine residents' understanding of the biostatistics and results in the medical literature. JAMA. 2007;298(9):1010–1022. doi:10.1001/jama.298.9.1010
- Core Post 3
Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G. How to use a subgroup analysis: users' guide to the medical literature. JAMA. 2014;311(4):405–411. doi:10.1001/jama.2013.285063
- Core Post 4
Kahan
DM, Peters E, Dawson E, Slovic P. Motivated Numeracy and Enlightened Self-Government. Behavioural Public Policy. 2013;1:54-86.
- Supplement 1
Gigerenzer G, Hertwig R, van den Broek E, Fasolo B, Katsikopoulos KV. "A 30% chance of rain tomorrow": how does the public understand probabilistic weather forecasts?. Risk Anal. 2005;25(3):623–629. doi:10.1111/j.1539-6924.2005.00608.x
- Supplement 2
Gueugniaud PY, David JS, Chanzy E, et al. Vasopressin and epinephrine vs. epinephrine alone in cardiopulmonary resuscitation. N Engl J Med. 2008;359(1):21–30. doi:10.1056/NEJMoa0706873
- Supplement 3
Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;2014(4):CD008965. Published 2014 Apr 10. doi:10.1002/14651858.CD008965.pub4
- Supplement 4
Watkins SJ. Conviction by mathematical error? Doctors and lawyers should get probability theory right. BMJ. 2000;320(7226):2–3. doi:10.1136/bmj.320.7226.2
|
|
1. Pre-Seminar CORE Reading Assignment
2. Pre-Seminar Problem Set
3. Post-Seminar Supplemental Reading
- Core 1
Kliff, Sarah. Inappropriate heart procedures are expensive and risky. And studies show thousands happen every year. Washington Post. 2012 Aug 8.
- Core 2
Harvey AH, Kirk U, Denfield GH, Montague PR. Monetary favors and their influence on neural responses and revealed preference. J Neurosci. 2010;30(28):9597–9602. doi:10.1523/JNEUROSCI.1086-10.2010
- Core 3
Lehmann LS, Puopolo AL, Shaykevich S, Brennan TA. Iatrogenic events resulting in intensive care admission: frequency, cause, and disclosure to patients and institutions. Am J Med. 2005;118(4):409–413. doi:10.1016/j.amjmed.2005.01.012
- Core 4
Neuman J, Korenstein D, Ross JS, Keyhani S. Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study. BMJ. 2011;343:d5621. Published 2011 Oct 11. doi:10.1136/bmj.d5621
- Core 5
Als-Nielsen B, Chen W, Gluud C, Kjaergard LL. Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?. JAMA. 2003;290(7):921–928. doi:10.1001/jama.290.7.921
- Core 6
Dunn AG, Arachi D, Hudgins J, Tsafnat G, Coiera E, Bourgeois FT. Financial conflicts of interest and conclusions about neuraminidase inhibitors for influenza: an analysis of systematic reviews. Ann Intern Med. 2014;161(7):513–518. doi:10.7326/M14-0933
- Core Post 1
Fanelli D. How many scientists fabricate and falsify research? A systematic review and meta-analysis of survey data. PLoS One. 2009;4(5):e5738. Published 2009 May 29. doi:10.1371/journal.pone.0005738
- Core Post 2
Cain, Daylian M., et al. The Dirt on Coming Clean: Perverse Effects of Disclosing Conflicts of Interest. The Journal of Legal Studies, vol. 34, no. 1, 2005, pp. 1–25. JSTOR, www.jstor.org/stable/10.1086/426699.
- Core Post 3
Sah S. Conflicts of interest and your physician: psychological processes that cause unexpected changes in behavior. J Law Med Ethics. 2012;40(3):482–487. doi:10.1111/j.1748-720X.2012.00680.x
- Supplement 1
Sekas G, Hutson WR. Misrepresentation of academic accomplishments by applicants for gastroenterology fellowships. Ann Intern Med. 1995;123(1):38–41. doi:10.7326/0003-4819-123-1-199507010-00006
- Supplement 2
Lenzer J. Why we can't trust clinical guidelines [published correction appears in BMJ. 2013;346:f3998]. BMJ. 2013;346:f3830. Published 2013 Jun 14. doi:10.1136/bmj.f3830
- Supplement 3
Bohannon J. Who's afraid of peer review?. Science. 2013;342(6154):60–65. doi:10.1126/science.342.6154.60
- Supplement 4
Kesselheim AS, Wang B, Studdert DM, Avorn J. Conflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosures. PLoS Med. 2012;9(8):e1001280. doi:10.1371/journal.pmed.1001280
|